2 Companies of Deotoglogical Ethics To Be Concern About

2 COMPANIES OF DEOTOGLOGICAL ETHICS TO BE CONCERN ABOUT   (By: Paul Goree  8/2015)

INDIVIDUAL WIT: DEONTOLOGICAL ETHICS (Right Theory):

Cali Reflecting, and I am upset about the intentional actions of some towards me, as they sought to demean and judicially correct my wrongs-as they saw them unjust.

Such wrongs as in 2005 when I petition the court clerk in Clark County, NV to prevent an eviction. The eviction resulted from a pre-mature sale of a property in an African American working class neighborhood, where the owners all owned their property and were near or in retirement. The pre-mature sale involved a pre-approved loan finance company in Southern California (LA/SD) and their questionable relationship with a local California bank. The pre-mature purchased ended up in a bulk sale of foreclosures purchased by a major banking organization as a regular transaction. The judge attended to my petition and a court hearing was placed over the eviction after the Constable placed the eviction.

MISUNDERSTANDING –FATAL RESULT: ULITIARTIAN ETHICS:

Another time, 2006. I was handed a progress report from a bank. I didn't think much of it at first. Looking at the report longer, I questioned usually activity from various issuing bank. Apparently for some reason all of these accounts had been issued a new card. This report was nationwide, that seemed impossible. After probing further I found out the re-issuing was due to a purchasing error on the manufacturing side. The manufacturing company CSR sales offices was located in Las Vegas, NV. The product was growth hormones, which at the time was causing some consumer confusion. I devised a quick 5 question survey to find out about the purchase and also to see for myself if the FDA PBS mass media notification were effective or confusing. Two questions (opening-after qualifying) focus on customer’s awareness. One asked had the customer seen any of the FDA public service announcements, warning Americans not to purchase growth hormones. The announcements utilized all 3 media forms (print, TV, and radio). The second question asked had the purchaser consulted their doctor before making the purchase. The final two questions focused on the packaging and purchase. These were open ended, and is where the majority of the information regarding the entire telemarketing sales call derived.

I had a sample of over 5 thousand (the original report) which I had to probe and research to identify 50 names with corresponding phone numbers nationwide. I only ended up doing 5 surveys, due to what I had learned. One of the respondents mother purchased the product and died as a result of using the product. This respondent was a lawyer and thanked me for calling seeming she had been waiting for some closure/conclusion-and now was determine on her own to find the facts regarding her mother death.  Another respondent was from Florida and he insisted his sister listen in on the survey since it was his conclusion that the product had killed their father and now began to result in complications of his will and family closure.

It seems that even with the FDA's public service announcement, which may or may not have been observed by the purchaser. These two senior citizens against doctors’ orders, purchased the product over the phone. When the product arrived it was packaged and mailed in such a way that opening it immediately expired any return options (seeming it was medication classified). Apparently 4 or so vials of the fluid liquid could be seen, but no instruction on how to administer the dosages. The Florida respondent his father ended up drinking a vial a week. Resulting in his death. Both respondents stated that they were not happy about the return policy of the unopened monthly arrivals of the product. The lawyer commented she later found out that when her mother made the purchase it was annually and billed as such. Hence she thought the credit card company was looking into the matter legally. Seeming they had sent her mother a new credit card.